6 research outputs found
Age-Related Differences of Risk Profile and Angiographic Findings in Patients with Coronary Heart Disease
Background: Coronary heart disease (CHD) is a major health problem which imposes a significant burden on health caresystems because of high morbidity and mortality. Objectives: To compare the risk factors profile for coronary heartdisease in young and old subjects. Methods: Total 100 patients (50 subjects less than 40 years of age and 50 subjectsmore than 40 years of age) with acute coronary syndrome or stable angina who were undergoing coronary angiogram inthe Department of Cardiology, University Cardiac Center, Bangabandhu Sheikh Mujib Medical University Dhaka, fromJuly 2006 to June 2008 were evaluated for the presence coronary artery disease risk factors e.g. hypertension, dyslipidemiaand smoking. Results: The mean age of the study population in younger group was (33.0 ± 6.4) years and in older group(52.0±8.6). The male to female ratio in both groups was 4:1. Smokers were more in younger group (70.0% vs. 46.0%) (p =0.032). Hypertension was less in the younger group (38.0% vs. 58.0%) (p = 0.045). Presence of diabetes was higher in theolder age group (34.0% vs. 4.0%) (p = 0.001). Higher incidence of family history of coronary heart disease was in theyounger age group. The total cholesterol was higher in older group (182.9 ± 33.1) vs. (171.1 ± 24.8 mg/dl) (p = 0.047). 68%of patients of older group and 38% of younger group had stenosis in left anterior descending artery (p = 0.003). Theinvolvement of left circumflex and right coronary artery in older age group were higher (56% and 66% respectively) thanthose in younger group (36% and 40% respectively) (p = 0.045 and p = 0.009). Conclusion: Ischemic heart disease inyounger adults < 40 years had different risk profile characteristics than older patients.Key words: Coronary heart disease; acute coronary syndrome; stable angina; risk factors.DOI: 10.3329/bsmmuj.v3i1.5508BSMMU J 2010; 3(1): 13-1
Biocontrol efficiency of microencapsulated Trichoderma harzianum coupled with organic additives against potato stem rot caused by Sclerotium rolfsii
Potato (Solanum tuberosum L.), world's fourth most carbohydrate supplying crop is often challenged by numerous pathogens among which Sclerotium rolfsii remains one of the most damaging during both growth and storage. As biocontrol is being preferred for their safety and sustainability, the present experiment was conducted for testing the biocontrol effectiveness of microencapsulated Trichoderma harzianum application in combination with organic additives against S. rolfsii. Five combinations (no T. harzianum+no organic additive [control]; T. harzianum+no organic additive; T. harzianum+rice husk biochar; T. harzianum+mustard oil cake; and T. harzianum+tea waste) were tested against two levels of S. rolfsii (absence [control] and presence) under a polyhouse environment. Prior to that, hyper-parasitism of T. harzianum against S. rolfsii was tested in vitro which showed 63.2% growth inhibition for the later. Polyhouse study revealed 16%, 25%, 19%, 21%, 38%, 27%, 9%, 13%, 28%, 20% and 9% average increase in plant height, branch number plant–1, leaf number plant–1, shoot dry matter, root dry matter, healthy tuber, total tuber yield, leaf greenness, net photosynthetic rate, total phenolic content and total antioxidant activity respectively with a subsequent reduction of 49% unhealthy tuber and 32% disease severity index due to T. harzianum+organic additive treatments. Disease suppression and growth recovery of S. rolfsii inoculated potato plants were found significantly better when T. harzianum was applied with organic additives compared to solitary application. The results of this study would provide useful information in strategizing T. harzianum formulation preparation for effective biocontrol of potato stem rot caused by S. rolfsii
Study on serum Lipoprotein (a) level in preeclamptic
It is a case control study which was design to know the association of serum Lipoprotein (a) level in preeclamptic (PE) in women. This study was carried out in department of Obstetrics and Gynecology, Sir Salimullah Medical College Hospital, Mitford, Dhaka. Total number of subjects was 100. Out of which 50 were cases and 50 were controls. Cases were physically and clinically proved PE patients. Controls were age, parity and gestational age matched. Three ml of blood were collected from each subjects, serum fasting LP(a) level were measured The mean age of study group was 24.49 ± 6.48 years. Serum Lipoprotein(a) level was 51.51 ± 29.38mg/dl Vs 17.40 ± 7.89 mg/dl in cases and controls respectively. This difference was statistically significant (p<0.001). Mean serum Lipoprotein(a) level was found to be raised in severe preeclampsia (74.87mg/dl) and lowest in control subject Severe preeclampsia was found to be associated with higher level of lipoprotein (a) than both control (p<0.01) and mild preeclamptic (p<0.01) subjects. Mild preeclampsia was also found to have higher average serum Lipoprotein (a) than the normal (P<0.01) subjects